Mendelson Karen, Aikawa Elena, Mettler Bret A, Sales Virna, Martin David, Mayer John E, Schoen Frederick J
Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA.
Cardiovasc Pathol. 2007 Sep-Oct;16(5):277-82. doi: 10.1016/j.carpath.2007.03.008. Epub 2007 Jun 21.
We hypothesized that cell-seeded patches implanted into sheep pulmonary artery would undergo progressive and complete healing into a viable structure well integrated with the arterial wall.
Autologous ovine blood-derived endothelial progenitor cells (EPCs) and bone marrow-derived mesenchymal stem cells (MSCs) were isolated and cultured in vitro. MSCs and EPCs were seeded onto poly-4-hydroxybutyrate (P4HB)-coated polyglycolic acid (PGA) nonwoven biodegradable mesh scaffolds (10x20 mm) and cultured for 5 days in a laminar fluid flow system. Seeded patches were implanted into the wall of sheep pulmonary artery for 1-2 weeks (n=4) or 4-6 weeks (n=3). Preimplant and postexplant specimens were analyzed by histology and immunohistochemistry.
Unimplanted constructs contained alpha-smooth muscle actin (SMA)-positive cells and early extracellular matrix formation (primarily glycosaminoglycans). One week after implantation, seeded patches had surface thrombus formation and macrophage infiltration. Seeded patches implanted for 2 weeks showed granulation tissue, early pannus formation, macrophages, foreign body giant cells around disintegrating polymer, and early angiogenesis (microvessel formation). After 4 weeks in vivo, seeded patches contained glycosaminoglycans, collagen, and coverage of the luminal surface by host artery-derived pannus containing alpha-SMA-positive cells and laminated elastin; polymer scaffold degradation was almost complete with replacement by fibrous tissue containing viable cells.
This study shows that cell-seeded patches implanted in sheep pulmonary artery remodel to layered and viable tissue well integrated into the native arterial wall. The key remodeling processes included (1) intimal overgrowth at the luminal surface (pannus formation; neointima) and (2) granulation tissue formation and fibrosis with foreign body reaction.
我们推测,植入绵羊肺动脉的细胞接种补片将逐渐并完全愈合为与动脉壁良好整合的有活力结构。
分离并体外培养自体绵羊血液来源的内皮祖细胞(EPCs)和骨髓来源的间充质干细胞(MSCs)。将MSCs和EPCs接种到聚4-羟基丁酸酯(P4HB)涂层的聚乙醇酸(PGA)非织造可生物降解网状支架(10×20mm)上,并在层流系统中培养5天。将接种细胞的补片植入绵羊肺动脉壁1至2周(n = 4)或4至6周(n = 3)。通过组织学和免疫组织化学分析植入前和植入后的标本。
未植入的构建体含有α-平滑肌肌动蛋白(SMA)阳性细胞和早期细胞外基质形成(主要是糖胺聚糖)。植入后1周,接种细胞的补片有表面血栓形成和巨噬细胞浸润。植入2周的接种细胞补片显示有肉芽组织、早期血管翳形成、巨噬细胞、降解聚合物周围的异物巨细胞以及早期血管生成(微血管形成)。体内植入4周后,接种细胞的补片含有糖胺聚糖、胶原蛋白,管腔表面被含有α-SMA阳性细胞和分层弹性蛋白的宿主动脉来源的血管翳覆盖;聚合物支架降解几乎完成,被含有活细胞的纤维组织替代。
本研究表明,植入绵羊肺动脉的细胞接种补片可重塑为与天然动脉壁良好整合的分层有活力组织。关键的重塑过程包括(1)管腔表面的内膜过度生长(血管翳形成;新生内膜)和(2)肉芽组织形成及伴有异物反应的纤维化。